Weight LossNCT03046641
Exercise Duration Models, in Middle-aged Men
A study testing Continuous training and The interval training in people with Weight Loss, run by P.L.Shupik National Medical Academy of Post-Graduate Education.
Trial summary
Duration of exercise is an important factor among the medical guides for weight loss. However, there is still little knowledge about other its models in middle-aged and older men. Read more about this study
- Who is it for?
- Ages 45 to 75 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Weight Loss
- What is being tested?
- Continuous training and The interval training
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 82 participants
- Where
- No sites listed yet
- Study dates
- Nov 2014to Feb 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 75 years
- Men only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Sedentary lifestyle
- Good Health
- Weight stability
Who cannot join
- Abnormality or history of Disease
About this study
Official title: The Study of Various Models of Exercise Duration on Weight Loss and Lipid Profile in Sedentary Overweight/Obese Middle-aged Men
Duration of exercise is an important factor among the medical guides for weight loss. However, there is still little knowledge about other its models in middle-aged and older men. The present study aimed to determine the effects of the interval training on weight loss and lipid profile, and to compare its efficiency with the continuous training.
Read the detailed description
Participants included sedentary men (age 45-75 years) with overweight or obesity (n= 82). They were randomly divided into two groups including continuous exercise, and interval exercise. The weight assessment parameters including change in weight and body composition, blood sample tests were performed pre- and three month post-intervention.
- Conditions
- Weight Loss
- Being tested
- Continuous training, The interval training
- Keywords
- Caloric Restriction, Dietary Formulations, Exercise, Men
- Medical subject headings
- Weight Loss, Motor Activity, Multiple Endocrine Neoplasia Type 1
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Continuous trainingOther
Also called group I
Study group I (42 participants) received the continuous training.
The interval trainingOther
Also called group II
Study group II (40 participants) received the interval training.
| Study group | Role | What they receive |
|---|---|---|
| continuous training group | Experimental | With the continuous training program Receives: Other: Continuous training |
| interval training group | Experimental | With the interval training program Receives: Other: The interval training |
What is being measured
The primary outcome is the main question the study is designed to answer.
4-item
weight, lipid profile (HDL, LDL, Cholesterol)
Measured: 3 months
Secondary outcomes (1)
4-item
weight, lipid profile (HDL, LDL, Cholesterol)
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Feb 2017 (estimated)
- Study startNov 2014
- Primary completionOct 2016
- Study completionFeb 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Weight LossStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 82 participants (actual)
Sponsor and investigators
- Lead sponsor
- P.L.Shupik National Medical Academy of Post-Graduate Education
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohammadreza Rezaeipour, MD, PhD, University of Sistan and Baluchestan
- Investigators
- Mohammadreza Rezaeipour, M.D., PhD., Principal investigator, Member of Scientific Board in Physical Education and Sport Sciences of Sistan and Baluchestan University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03046641
- Sponsor's protocol ID
- No Grant-2
- Status last verified
- Feb 2017
- First submitted
- 21 Jun 2013
- Last updated
- 20 Feb 2017
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Feb 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Study of Various Models of Exercise Duration on Weight Loss and Lipid Profile in Sedentary Overweight/Obese Middle-aged Men
- ClinicalTrials.gov ID
- NCT03046641
- Acronym / sponsor ID
- No Grant-2
- Conditions
- Weight Loss
- Keywords
- Caloric Restriction, Dietary Formulations, Exercise, Men
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 82 participants (actual)
- Lead sponsor
- P.L.Shupik National Medical Academy of Post-Graduate EducationUniversity, hospital or other
- Study start
- Nov 2014 (actual)
- Primary completion
- Oct 2016 (actual)
- Study completion
- Feb 2017 (actual)
- First posted
- 8 Feb 2017 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Duration of exercise is an important factor among the medical guides for weight loss. However, there is still little knowledge about other its models in middle-aged and older men. The present study aimed to determine the effects of the interval training on weight loss and lipid profile, and to compare its efficiency with the continuous training.
Detailed description
Participants included sedentary men (age 45-75 years) with overweight or obesity (n= 82). They were randomly divided into two groups including continuous exercise, and interval exercise. The weight assessment parameters including change in weight and body composition, blood sample tests were performed pre- and three month post-intervention.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| continuous training group | Experimental | Other: Continuous trainingWith the continuous training program |
| interval training group | Experimental | Other: The interval trainingWith the interval training program |
Who may qualify
- Ages
- 45 to 75 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Sedentary lifestyle
- Good Health
- Weight stability
Key exclusion criteria (1 listed)
- Abnormality or history of Disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Continuous trainingAlso: group IStudy group I (42 participants) received the continuous training. | Other | continuous training group |
| The interval trainingAlso: group IIStudy group II (40 participants) received the interval training. | Other | interval training group |
Primary outcome
4-item
Time frame: 3 months
weight, lipid profile (HDL, LDL, Cholesterol)
1 secondary outcome
4-item
Time frame: 3 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Feb 2017.
- Individual participant dataSharing planned: No
Related trials for Weight Loss
Recruiting
The Sleep2BWell Trial
Blood Pressure, Sleep Health
Recruiting
iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) +Optimized Lifestyle Intervention (OLI) vs Sham + OLI for Weight Loss
Overweight and/or Obesity, Metabolic Syndrome
RecruitingPhase 4
Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss
Class I/II Obesity
Active, not recruitingPhase 1/2
A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight
Overweight and Obesity
RecruitingPhase 4
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
Liver Cirrhoses, Portal Hypertension Related to Cirrhosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mohammadreza Rezaeipour, M.D., PhD. principal investigator
Member of Scientific Board in Physical Education and Sport Sciences of Sistan and Baluchestan University
Questions about this trial
What is this clinical trial studying?
A study testing Continuous training and The interval training in people with Weight Loss, run by P.L.Shupik National Medical Academy of Post-Graduate Education.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
4-item (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2017; AzTrials last refreshed its copy on 27 Oct 2026.